Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 July 2023 | Story Valentino Ndaba | Photo Supplied
UFS African Reparation
The University of the Free State Africa Reparations Hub (UFSARH) aims to anchor the African reparations agenda through scholarship and advocacy.

The University of the Free State (UFS) is set to launch an Africa Reparations Hub, which will serve as a hub for Pan-African-led reparations scholarship, policy, and advocacy. The University of the Free State Africa Reparations Hub (UFSARH) will be housed within the UFS Faculty of Law.

“The UFSARH vision is to be an international academic forum to institutionalise, promote and advance the Africa reparations agenda,” says Khanya Motshabi, UFSARH Strategic Lead. “Its mission anchors the Africa reparations agenda through research, scholarship, and advocacy. The hub is underpinned by the values and principles of excellence, ubuntu, social justice, African-centredness, and Pan-African epistemological grounding of all its initiatives, operations, activities, and undertakings.”

As a Pan-African centre, the hub will work at national, regional, and international levels, and resolves to conduct research, offer education, develop policies, and advocate for reparations via a UFSARH Panel of Experts on Africa Reparations. It will have three key facets: a database on Africans for Africa, which will serve as a repository for resources and an information archive; it will serve as home to the expert group on Africa reparations; and anchor a research group on the subject.

Convened by Dr Catherine Namakula, the hub will be established under the auspices of the Faculty of Law and the Department of Public Law, and would be accountable to an advisory board led by Prof Serges Kamga, Dean of the Faculty of Law, and Prof Shaun De Freitas, Head of the Department of Public Law.


Addressing the wrongs of the past

As a home for a repository of all resources on Africa reparations, the UFSARH aims to support the pursuit of justice for historical injustices such as enslavement, apartheid, colonialism, neo-colonialism, and economic exploitation and extortion. In addition, the UFSARH’s contribution to global equality and social justice aligns with the UFS’s Vision 130 strategic plan.

The UFSARH aims to unify and strengthen the fragmented African reparations narrative by serving as a prominent legal, academic, and transdisciplinary forum.

“The hub would also anchor and reinforce the Africa Reparations Agenda of the African Union. It shall bolster the increased awareness and activism of African government, non-government, civil society, and individual actors through grounding relevant political, diplomatic, normative, and academic activities and initiatives,” says Dr Shelton Makore, UFSARH Technical Lead.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept